All Years | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
2017 — 9 Books and Research Papers Citing DrugPatentWatch
Gorry, P. (2017). Orphan Drug Legislation: Evaluation of the Impact of Market Exclusivity Extension.
This paper examines the effects of extended market exclusivity on orphan drugs, utilizing DrugPatentWatch data to assess patent expiration timelines. The study finds that extended exclusivity periods can significantly delay generic market entry, thereby affecting drug pricing and accessibility. The findings underscore the importance of patent strategy in balancing innovation incentives with public health considerations.
Andriani, P., Ali, A., & Mastrogiorgio, M. (2017). Measuring Exaptation and Its Impact on Innovation, Search, and Problem Solving. Organization Science, 28(2), 426–444. https://doi.org/10.1287/orsc.2017.1106
This article explores the concept of exaptation in innovation processes, citing DrugPatentWatch to analyze patent data trends. The authors highlight how shifts in patenting activity can indicate broader changes in research directions and technological advancements. The study provides insights into how patent data can inform strategic decision-making in research and development.
Friedman, Y. (2017). Where Are Drugs Invented, and Why Does It Matter? ACS Medicinal Chemistry Letters, 8(12), 1231–1233. https://doi.org/10.1021/acsmedchemlett.7b00494
Friedman investigates the geographical distribution of pharmaceutical inventions, utilizing DrugPatentWatch data to map patent filings. The study reveals that patent activity is concentrated in specific regions, influencing global drug development and access. The findings suggest that understanding patent geography is crucial for market entry strategies and policy-making.
Mucke, H. (2017). Repurposing for Alzheimer's and Parkinson's Diseases. In Drug Repositioning: Approaches and Applications for Neurodegenerative Diseases (pp. 123–145). Elsevier. https://doi.org/10.1016/B978-0-12-804302-0.00009-9
Mucke discusses the potential of drug repurposing for treating Alzheimer's and Parkinson's diseases, referencing DrugPatentWatch to identify existing patents of interest. The chapter emphasizes the importance of patent analysis in identifying viable candidates for repurposing, thereby accelerating the drug development process. The insights are valuable for researchers and companies exploring cost-effective therapeutic options.
Jayakrishnapillai, P. V., Nair, S. V., & Kumar, V. (2017). Current Trend in Drug Delivery Considerations for Subcutaneous Insulin Depots to Treat Diabetes. Colloids and Surfaces B: Biointerfaces, 159, 1–12. https://doi.org/10.1016/j.colsurfb.2017.07.015
This review article examines advancements in subcutaneous insulin delivery systems, citing DrugPatentWatch to analyze patent trends in insulin formulations. The authors identify emerging technologies and patent strategies that could influence the future of diabetes treatment. The paper provides a comprehensive overview of the evolving landscape in insulin delivery, highlighting opportunities for innovation.
Weintraub, S. J. (2017). Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal. CNS Drugs, 31(12), 1093–1104. https://doi.org/10.1007/s40263-017-0502-4
Weintraub reviews the use of diazepam in managing alcohol withdrawal symptoms, referencing DrugPatentWatch to assess the patent status of related formulations. The article discusses the implications of patent expirations on treatment options and market competition. The findings are pertinent for clinicians and pharmaceutical companies involved in addiction treatment.
Stokes, W., Fenton, C., Clement, F., & James, M. (2017). The Efficacy and Safety of 12 Weeks of Sofosbuvir and Ledipasvir Versus Sofosbuvir, Ledipasvir, and Ribavirin in Patients with Chronic Hepatitis C, Genotype 1. Canadian Journal of Gastroenterology and Hepatology, 2017, 1–8. https://doi.org/10.1155/2017/4830521
This study compares the efficacy and safety of different treatment regimens for chronic hepatitis C, utilizing DrugPatentWatch data to evaluate the patent landscape of the involved drugs. The research highlights the role of patent strategies in shaping treatment options and market dynamics. The insights are valuable for healthcare providers and policymakers in optimizing treatment protocols.
Deftereos, S. N., Persidis, A., & Persidis, D. (2017). 4 Systematic Drug Repositioning: Approaches and Applications for Neurodegenerative Diseases. In Drug Repositioning: Approaches and Applications for Neurodegenerative Diseases (pp. 1–15). Elsevier. https://doi.org/10.1016/B978-0-12-804302-0.00001-3
This book chapter explores systematic approaches to drug repositioning, citing DrugPatentWatch to analyze patent data related to existing drugs. The authors discuss methodologies for identifying new therapeutic uses for approved drugs, emphasizing the importance of patent analysis in the repositioning process. The chapter provides a framework for researchers and companies interested in drug repurposing.
Araújo, J. M. (2017). A Indústria Farmacêutica Brasileira e a Oferta de Medicamentos para o Tratamento da Insuficiência Cardíaca no SUS. Repositório UFBA. Retrieved from repositorio.ufba.br
Araújo examines the Brazilian pharmaceutical industry and its role in supplying medications for heart failure treatment within the public health system, referencing DrugPatentWatch to assess patent expirations and generic drug availability. The study highlights the impact of patent policies on drug accessibility and healthcare costs in Brazil. The findings are relevant for policymakers and healthcare providers aiming to improve treatment access.
